CEST MRI: Practical considerations and useful applications
CEST MRI: Practical considerations and useful applications

Imaging Alzheimer’s disease using CEST MRI

On Demand Session

Webinar Overview

Alzheimer’s disease (AD) is the most common type of dementia, and is a multifactorial neurodegenerative disease. While protein pathology related to beta-amyloid plaques and neurofibrillary tau deposits are observed in AD, early molecular alterations are not very clear yet, especially pathology related to the dysfunction of glymphatic clearance.


Kannie Chan discusses, how she and her team demonstrated that CEST MRI could identify an obvious decrease in CSF clearance at early stage of AD in a mouse model. Moreover, altered glucose uptake and kinetics in both CSF and parenchyma were detected. These alterations in multiple CEST parameters were not observed in normal age-matched mice. Together with deep-learning assisted CEST assessment of protein alterations, CEST MRI could provide additional multi-parametric assessments of AD pathology non-invasively.

Speaker

Prof. Kannie Chan

Associate Professor of Biomedical Engineering at City University of Hong Kong, Hong Kong
and Adjunct Faculty at Johns Hopkins University, Baltimore, MD, USA

Prof. Kannie Chan is an Associate Professor of Biomedical Engineering at City University of Hong Kong and an Adjunct Faculty at Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University. Her research focuses on the development of biomaterials and imaging approaches to facilitate clinical translations of cancer therapy and cell therapy, and early diagnosis of neurodegenerative diseases. She developed imaging of glucose using CEST-MRI, which has many implications in diseases in the brain, such as Alzheimer’s disease. 

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.